BayMark Health first- and second-lien term loan price talk emerges

By Sara Rosenberg

New York, May 21 – BayMark Health Services released price talk on its $360 million first-lien term loan, $100 million delayed-draw first-lien term loan, $100 million second-lien term loan and $50 million delayed-draw second-lien term loan, according to a market source.

The first-lien term loan debt is talked at Libor plus 500 basis points with a 1% Libor floor and an original issue discount of 99, and the second-lien term loan debt is talked at Libor plus 850 bps with a 1% Libor floor and a discount of 98.5, the source said.

The company’s $650 million of credit facilities also include a $40 million revolver.

Capital One, BMO Capital Markets and KeyBanc Capital Markets are the leads on the deal that launched with a call on Thursday.

Commitments are due on June 4, the source added.

Proceeds will be used to refinance existing debt and fund near-term acquisitions.

BayMark is a Lewisville, Tex.-based provider of medication-assisted treatment to patients in recovery from substance use disorder.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.